Carroll Financial Associates’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $860K | Sell |
5,035
-152
| -3% | -$25.3K | 0.05% | 195 |
|
|
2021
Q3 | $859K | Sell |
5,187
-452
| -8% | -$77.8K | 0.05% | 199 |
|
|
2021
Q2 | $1.01M | Sell |
5,639
-155
| -3% | -$28.3K | 0.06% | 178 |
|
|
2021
Q1 | $1.12M | Sell |
5,794
-162
| -3% | -$31.2K | 0.07% | 161 |
|
|
2020
Q4 | $1.2M | Buy |
5,956
+4
| +0.1% | +$828 | 0.08% | 146 |
|
|
2020
Q3 | $1.25M | Sell |
5,952
-150
| -2% | -$33.4K | 0.1% | 130 |
|
|
2020
Q2 | $1.34M | Buy |
6,102
+727
| +14% | +$145K | 0.11% | 114 |
|
|
2020
Q1 | $931K | Buy |
5,375
+2,479
| +86% | +$410K | 0.09% | 136 |
|
|
2019
Q4 | $444K | Buy |
2,896
+14
| +0.5% | +$2.09K | 0.04% | 233 |
|
|
2019
Q3 | $437K | Sell |
2,882
-58
| -2% | -$9.17K | 0.04% | 234 |
|
|
2019
Q2 | $450K | Sell |
2,940
-126
| -4% | -$19.2K | 0.04% | 227 |
|
|
2019
Q1 | $491K | Sell |
3,066
-7
| -0.2% | -$1.09K | 0.05% | 194 |
|
|
2018
Q4 | $475K | Sell |
3,073
-61
| -2% | -$9.5K | 0.05% | 160 |
|
|
2018
Q3 | $471K | Sell |
3,134
-102
| -3% | -$14.5K | 0.05% | 177 |
|
|
2018
Q2 | $437K | Sell |
3,236
-67
| -2% | -$8.27K | 0.05% | 183 |
|
|
2018
Q1 | $439K | Sell |
3,303
-99
| -3% | -$13.3K | 0.05% | 179 |
|
|
2017
Q4 | $506K | Buy |
3,402
+2
| +0.1% | +$272 | 0.06% | 166 |
|
|
2017
Q3 | $438K | Sell |
3,400
-8
| -0.2% | -$1.07K | 0.05% | 171 |
|
|
2017
Q2 | $454K | Buy |
3,408
+2
| +0.1% | +$270 | 0.05% | 170 |
|
|
2017
Q1 | $459K | Buy |
3,406
+1
| +0% | +$130 | 0.06% | 156 |
|
|
2016
Q4 | $408K | Buy |
3,405
+44
| +1% | +$5.19K | 0.06% | 162 |
|
|
2016
Q3 | $420K | Buy |
3,361
+12
| +0.4% | +$1.57K | 0.06% | 158 |
|
|
2016
Q2 | $463K | Buy |
3,349
+1
| +0% | +$130 | 0.08% | 142 |
|
|
2016
Q1 | $422K | Buy |
3,348
+131
| +4% | +$16.7K | 0.08% | 149 |
|
|
2015
Q4 | $408K | Buy |
3,217
+100
| +3% | +$12.4K | 0.08% | 136 |
|
|
2015
Q3 | $380K | Buy |
3,117
+342
| +12% | +$38.4K | 0.08% | 140 |
|
|
2015
Q2 | $289K | Sell |
2,775
-1,050
| -27% | -$113K | 0.06% | 153 |
|
|
2015
Q1 | $422K | Buy |
3,825
+1,450
| +61% | +$157K | 0.19% | 88 |
|
|
2014
Q4 | $260K | Sell |
2,375
-1,502
| -39% | -$150K | 0.17% | 97 |
|
|
2014
Q3 | $392K | Buy |
3,877
+351
| +10% | +$31.7K | 0.12% | 108 |
|
|
2014
Q2 | $322K | Buy |
3,526
+493
| +16% | +$44.2K | 0.09% | 128 |
|
|
2014
Q1 | $267K | Buy |
3,033
+1,287
| +74% | +$113K | 0.09% | 129 |
|
|
2013
Q4 | $161K | Buy |
1,746
+50
| +3% | +$4.5K | 0.06% | 159 |
|
|
2013
Q3 | $138K | Hold |
1,696
| – | – | 0.05% | 169 |
|
|
2013
Q2 | $141K | Buy |
+1,696
| New | +$146K | 0.07% | 130 |
|
Other funds holding CLX
CIP
Carroll Financial Associates's CLX Position: Q4 2021 in Review
Carroll Financial Associates reduced its Clorox (CLX) stake by 2.9% in Q4 2021, selling an estimated $25.3K and leaving 5,035 shares worth $860K. The position accounts for 0.05% of the portfolio, ranked #195.
Carroll Financial Associates first reported a position in CLX in Q2 2013 and has held it in 35 quarters since. The position peaked at $1.34M in Q2 2020. 1,219 funds tracked by Wall St. Rank hold CLX as of Q4 2021.
- Carroll Financial Associates held 5,035 shares of Clorox worth $860K as of Q4 2021.
- Carroll Financial Associates sold 152 Clorox shares in Q4 2021, an estimated $25.3K.
- Clorox made up 0.05% of Carroll Financial Associates's portfolio in Q4 2021, its #195 holding.
- Carroll Financial Associates first reported a position in Clorox in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Clorox position peaked at $1.34M in Q2 2020.
- 1,219 funds tracked by Wall St. Rank held Clorox as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.